from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3595c/PE_PGRS59

LFCtreatmentdescriptionclass of inhibitor

1.774

Amikacinug/mL Amikacintranslation

0.882

Cap5-10ug/mL Capreomycintranslation

1.055

Rox10-50 ug/mL Roxithromycintranslation

0.038

SM2-5 ug/mL Streptomycintranslation

1.973

Tet5-10 ug/mL Tetracyclinetranslation

-2.403

Rif0.2-5ug/mL Rifampicintranscription

-2.080

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.477

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

1.776

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.412

CPZ10-50 ug/mL Chlorpromazinerespiration

0.106

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.329

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

2.385

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.469

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.055

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.385

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.097

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.732

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.217

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.961

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.388

KCN5-20 ug/mL Potassium cyaniderespiration

0.167

NaN30.2-2 mM Sodium aziderespiration

-0.091

Nigericin50 uM Nigericinrespiration

-0.055

TRC10-150 ug/mL Triclosanrespiration

0.834

TRZ10-25 ug/mL Thioridazinerespiration

1.758

Valinomycin0.5-10 uM Valinomycinrespiration

-0.253

ZnSO42 mM ZnSO4respiration

-0.465

menadione6-10 ug/mL Menadionerespiration

-0.185

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.830

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.578

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.505

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.175

NRP_1Non-replicating persistence stage 1dosRassociated

-0.078

Amp0.2mg/mL AmpicillincellWall

0.200

Cephalexin20-100 ug/mL CephalexincellWall

-0.558

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.997

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.052

EMB10-20 ug/mL EthambutolcellWall

0.288

Eta12-40 ug/mL EthionamidecellWall

0.881

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.786

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.100

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.019

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.147

BZA0.12 mg/mL BenzamidearomaticAmides

0.249

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.693

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.290

H2O24 mM hydrogen peroxideDNAdamaging

-1.065

Levo10 ug/mL LevofloxacinDNAdamaging

-0.574

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.375

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.322

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.191

UVUV-irradiationDNAdamaging

1.397

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.729

Antimycin12.5-50 ug/mL Antimycin A?

-0.829

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.889

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.576

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.786

PA8240.2-2 ug/mL PA-824?

0.911

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.180

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.545

Verapamil50 uM Verapamil?

-1.079

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.710

methoxatin10-20 ug/mL Methoxatin?